|
1
|
Martel-Pelletier J: Pathophysiology of
osteoarthritis. Osteoarthr Cartilage. 12 Suppl A:S31–S33. 2014.
View Article : Google Scholar
|
|
2
|
Johnson E, Charchandi A, Babis G and
Soucacos P: Apoptosis in osteoarthritis: Morphology, mechanisms,
and potential means for therapeutic intervention. J Surg Orthop
Adv. 17:147–152. 2007.
|
|
3
|
Grishko V, Xu M, Ho R, Mates A, Watson S,
Kim JT, Wilson GL and Pearsall AW IV: Effects of hyaluronic acid on
mitochondrial function and mitochondria-driven apoptosis following
oxidative stress in human chondrocytes. J Biol Chem. 284:9132–9139.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dave M, Attur M, Palmer G, Al-Mussawir HE,
Kennish L, Patel J and Abramson SB: The antioxidant resveratrol
protects against chondrocyte apoptosis via effects on mitochondrial
polarization and ATP production. Arthritis Rheum. 58:2786–2797.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Blanco FJ, Rego I and Ruiz-Romero C: The
role of mitochondria in osteoarthritis. Nat Rev Rheumatol.
7:161–169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goldring MB: Osteoarthritis and cartilage:
The role of cytokines. Curr Rheumatol Rep. 2:459–465. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bassleer CT, Combal JP, Bougaret S and
Malaise M: Effects of chondroitin sulfate and interleukin-1 beta on
human articular chondrocytes cultivated in clusters. Osteoarthr
Cartilage. 6:196–204. 1998. View Article : Google Scholar
|
|
8
|
Daheshia M and Yao JQ: The interleukin 1
beta pathway in the pathogenesis of osteoarthritis. J Rheumatol.
35:2306–2312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasuhara R, Miyamoto Y, Akaike T, Akuta T,
Nakamura M, Takami M, Morimura N, Yasu K and Kamijo R:
Interleukin-1beta induces death in chondrocyte-like ATDC5 cells
through mitochondrial dysfunction and energy depletion in a
reactive nitrogen and oxygen species-dependent manner. Biochem J.
389:315–323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sanchez C, Deberg MA, Piccardi N, Msika P,
Reginster JY and Henrotin YE: Osteoblasts from the sclerotic
subchondral bone downregulate aggrecan but upregulate
metalloproteinases expression by chondrocytes. This effect is
mimicked by interleukin-6,-1beta and oncostatin M pre-treated
non-sclerotic osteoblasts. Osteoarthr Cartilage. 13:979–987. 2005.
View Article : Google Scholar
|
|
11
|
Banno N, Akihisa T, Tokuda H, Yasukawa K,
Higashihara H, Ukiya M, Watanabe K, Kimura Y, Hasegawa J and
Nishino H: Triterpene acids from the leaves of Perilla frutescens
and their anti-inflammatory and antitumor-promoting effects. Biosci
Biotech Biochem. 68:85–90. 2004. View Article : Google Scholar
|
|
12
|
Song YL, Zhang L, Gao JM, Du GH and Cheng
YX: Speciosaperoxide, a new triterpene acid, and other terpenoids
from Chaenomeles speciosa. J Asian Nat Prod Res. 10:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bortalanza LB, Ferreira J, Hess SC, Delle
Monache F, Yunes RA and Calixto JB: Anti-allodynic action of the
tormentic acid, a triterpene isolated from plant, against
neuropathic and inflammatory persistent pain in mice. Eur J
Pharmacol. 453:203–208. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
An HJ, Kim IT, Park HJ, Kim HM, Choi JH
and Lee KT: Tormentic acid, a triterpenoid saponin, isolated from
Rosa rugosa, inhibited LPS-induced iNOS, COX-2, and TNF-α
expression through inactivation of the nuclear factor-κb pathway in
RAW 264.7 macrophages. Int Immunopharmacol. 11:504–510. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin X, Zhang S, Huang R, Tan S, Liang S,
Wu X, Zhuo L and Huang Q: Protective effect of tormentic acid from
Potentilla chinensis against lipopolysaccharide/D-galactosamine
induced fulminant hepatic failure in mice. Int Immunopharmacol.
19:365–372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shakibaei M and Merker HJ: beta1-Integrins
in the cartilage matrix. Cell Tissue Res. 296:565–573. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aigner T and Kim HA: Apoptosis and
cellular vitality: Issues in osteoarthritic cartilage degeneration.
Arthritis Rheum. 46:1986–1996. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goldring MB: Update on the biology of the
chondrocyte and new approaches to treating cartilage diseases. Best
Pract Res Clin Rheumatol. 20:1003–1025. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mistry D, Oue Y, Chambers MG, Kayser MV
and Mason RM: Chondrocyte death during murine osteoarthritis.
Osteoarthr Cartilage. 12:131–141. 2004. View Article : Google Scholar
|
|
20
|
Caron JP, Fernandes JC, Martel-Pelletier
J, Tardif G, Mineau F, Geng C and Pelletier JP: Chondroprotective
effect of intraarticular injections of interleukin-1 receptor
antagonist in experimental osteoarthritis. Suppression of
collagenase-1 expression. Arthritis Rheum. 39:1535–1544. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joosten LA, Helsen MM, Saxne T, van De Loo
FA, Heinegard D and van Den Berg WB: IL-1alpha beta blockade
prevents cartilage and bone destruction in murine type II
collagen-induced arthritis, whereas TNF-alpha blockade only
ameliorates joint inflammation. J Immunol. 163:5049–5055.
1999.PubMed/NCBI
|
|
22
|
Largo R, Alvarez-Soria M, Dıez-Ortego I,
Calvo E, Sanchez-Pernaute O, Egido J and Herrero-Beaumont G:
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human
osteoarthritic chondrocytes. Osteoarthritis Cartilage. 11:290–298.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mazzetti I, Grigolo B, Pulsatelli L,
Dolzani P, Silvestri T, Roseti L, Meliconi R and Facchini A:
Differential roles of nitric oxide and oxygen radicals in
chondrocytes affected by osteoarthritis and rheumatoid arthritis.
Clin Sci. 101:593–599. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Venkatesan N, Barre L, Benani A, Netter P,
Magdalou J, Fournel-Gigleux S and Ouzzine M: Stimulation of
proteoglycan synthesis by glucuronosyltransferase-I gene delivery:
A strategy to promote cartilage repair. Proc Natl Acad Sci USA.
101:pp. 18087–18092. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Gai P, Xu R, Zheng Y, Lv S, Li Y
and Liu S: Shikonin protects chondrocytes from
interleukin-1beta-induced apoptosis by regulating PI3K/Akt
signaling pathway. Int J Clin Exp Pathol. 8:2982015.PubMed/NCBI
|
|
26
|
Samali A, Zhivotovsky B, Jones D, Nagata S
and Orrenius S: Apoptosis: Cell death defined by caspase
activation. Cell Death Differ. 6:495–496. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shakibaei M, Schulze-Tanzil G, John T and
Mobasheri A: Curcumin protects human chondrocytes from
IL-1beta-induced inhibition of collagen type II and beta1-integrin
expression and activation of caspase-3: An immunomorphological
study. Anna Anat. 187:487–497. 2005. View Article : Google Scholar
|
|
28
|
Chen J, Chu Y, Cao J, Yang Z, Guo X and
Wang Z: T-2 toxin induces apoptosis, and selenium partly blocks,
T-2 toxin induced apoptosis in chondrocytes through modulation of
the Bax/Bcl-2 ratio. Food Chem Toxicol. 44:567–573. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Malemud CJ and Gillespie HJ: The role of
apoptosis in arthritis. Curr Rheumatol Rev. 1:131–142. 2005.
View Article : Google Scholar
|
|
30
|
Sugimori K, Matsui K, Motomura H, Tokoro
T, Wang J, Higa S, Kimura T and Kitajima I: BMP-2 prevents
apoptosis of the N1511 chondrocytic cell line through
PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab.
23:411–419. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oh CD and Chun JS: Signaling mechanisms
leading to the regulation of differentiation and apoptosis of
articular chondrocytes by insulin-like growth factor-1. J Biol
Chem. 278:36563–36571. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ikegami D, Akiyama H, Suzuki A, Nakamura
T, Nakano T, Yoshikawa H and Tsumaki N: Sox9 sustains chondrocyte
survival and hypertrophy in part through Pik3ca-Akt pathways.
Development. 138:1507–1519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stiles BL: PI-3-K and AKT: Onto the
mitochondria. Adv Drug Deliver Rev. 61:1276–1282. 2009. View Article : Google Scholar
|
|
34
|
Yin W, Park JI and Loeser RF: Oxidative
stress inhibits insulin-like growth factor-I induction of
chondrocyte proteoglycan synthesis through differential regulation
of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling
pathways. J Biol Chem. 284:31972–31981. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Starkman BG, Cravero JD, Delcarlo M and
Loeser RF: IGF-I stimulation of proteoglycan synthesis by
chondrocytes requires activation of the PI 3-kinase pathway but not
ERK MAPK. Biochem J. 389:723–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
